VRPX
Geode Capital Management’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-41,899
| Closed | -$15.5K | – | 4578 |
|
2024
Q4 | $15.5K | Buy |
41,899
+13,928
| +50% | +$5.15K | ﹤0.01% | 4405 |
|
2024
Q3 | $19.4K | Buy |
+27,971
| New | +$19.4K | ﹤0.01% | 4397 |
|
2024
Q1 | – | Sell |
-63,928
| Closed | -$20.2K | – | 4678 |
|
2023
Q4 | $20.2K | Hold |
63,928
| – | – | ﹤0.01% | 4513 |
|
2023
Q3 | $51.2K | Sell |
63,928
-2,110
| -3% | -$1.69K | ﹤0.01% | 4415 |
|
2023
Q2 | $72K | Hold |
66,038
| – | – | ﹤0.01% | 4431 |
|
2023
Q1 | $51.6K | Hold |
66,038
| – | – | ﹤0.01% | 4510 |
|
2022
Q4 | $41K | Sell |
66,038
-185
| -0.3% | -$115 | ﹤0.01% | 4649 |
|
2022
Q3 | $78K | Hold |
66,223
| – | – | ﹤0.01% | 4663 |
|
2022
Q2 | $111K | Buy |
66,223
+3,210
| +5% | +$5.38K | ﹤0.01% | 4551 |
|
2022
Q1 | $139K | Buy |
63,013
+15,342
| +32% | +$33.8K | ﹤0.01% | 4535 |
|
2021
Q4 | $163K | Buy |
47,671
+37,626
| +375% | +$129K | ﹤0.01% | 4567 |
|
2021
Q3 | $48K | Buy |
+10,045
| New | +$48K | ﹤0.01% | 4791 |
|